TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 35 filers reported holding TRANSLATE BIO INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,047,319,000 | +87.3% | 38,029 | +12.1% | 0.00% | – |
| Q1 2021 | $559,176,000 | -32.6% | 33,910 | -24.6% | 0.00% | – |
| Q4 2020 | $829,350,000 | +61.6% | 45,000 | +19.4% | 0.00% | – |
| Q3 2020 | $513,097,000 | +53.1% | 37,700 | +101.6% | 0.00% | – |
| Q2 2020 | $335,104,000 | -19.1% | 18,700 | -54.8% | 0.00% | – |
| Q3 2018 | $414,000,000 | -20.9% | 41,400 | 0.0% | 0.00% | – |
| Q2 2018 | $523,710,000 | – | 41,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |